Investing Profile

Meg Krench

InvestorVC
Investor, Sanofi Ventures at Sanofi
sanofiventures.com/team/index...Cambridge, Massachusetts
Photo of Meg Krench, Investor at Sanofi Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Self-Employed Network
760 CONNECTIONS
Massachusetts Institute of Technology Network
617 CONNECTIONS
Massachusetts Institute of Technology Network
186 CONNECTIONS
Penn State University Network
112 CONNECTIONS
Private company Network
63 CONNECTIONS
cb
$5.0M - $10.0M
$7.5M
1
CompanyStageDateRound SizeTotal Raised
Memento Medicines
Series AJun 2026$93M
$93M
Co-investors: Dmitrij Hristodorov (Forbion), Zach Scheiner (RA Capital Management)
Writer Tufts UniversityPresent
Writer Private companyPresent
Director Veralox TherapeuticsPresent
Board Observer Korsana BiosciencesPresent
Director NormunityPresent
Director Eligo BiosciencePresent
Director Tufts UniversityPresent
Writer Scientific AmericanPresent
Visiting lecturer Tufts UniversityPresent
Neuroscience PhD Massachusetts Institute of TechnologyPresent
Instructor MIT MuseumPresent
Writer Self-EmployedPresent
Consulting Intern CBT AdvisorsPresent
Associate RA Capital ManagementPresent
Senior Associate RA Capital ManagementPresent
Director of BD - External Innovation Vertex PharmaceuticalsPresent
Board Observer Aliada TherapeuticsPresent
Board Co-Chair, Board Director New England Venture NetworkPresent
Investor, Sanofi Ventures SanofiPresent
Board Director Veralox TherapeuticsPresent
Board Observer NormunityPresent
Board Observer QurAlisPresent
Board Observer Eligo BiosciencePresent
Board Observer Draig TherapeuticsPresent
Board Observer Stealth Company (Meg Krench)Present
Penn State University Bachelor of Science (BS) Biology, Neuroscience
Massachusetts Institute of Technology Doctor of Philosophy (PhD) Neuroscience
Sign in with Google →
Sign in with Google →